Pharmacogenetics of the Response to Semaglutide in Mexican-Americans with Prediabetes - Cancer Prevention and Control Grand Rounds -- 9/19/2025

---

RSS

Friday, September 19, 2025, 12:00 PM - 1:00 PM, MD Anderson - Main Building, Houston, TX


AMA PRA Category 1 Credits™ (1.00 hours), ANCC - Nursing Contact Hour(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

This series will provide an overview of population and health services and research topics; i.e., collection, analysis and/or synthesis of health/practice data that improve health care or best practices. The goal is to address emerging areas relevant to cancer prevention research and practice, stimulate potential collaborations, and recognize and reduce barriers to prevention.

Objective(s): 1 Articulate research findings as they relate to cancer prevention; e.g., early screening detection, tobacco and smoking cessation, etc. 2 Recognize and reduce barriers to prevention comprehensively to increase the uptake of cancer prevention measures among patients, providers, and communities. 3 Advance collaboration and dialogue among clinicians, researchers, and study participants, cancer prevention and control efforts can become more holistic, patient-centered, and effective. 4 Execute and initiate new research projects, adaptations to ongoing research projects, or changes in practice to improve cancer prevention care with a systematic and strategic approach.
Location: MD Anderson - Main Building
Specialties: Gastroenterology, Gynecologic Oncology, Infectious Disease, Internal Medicine, Pulmonary Disease, Radiation Oncology, Preventive Medicine, Psychiatry, Public Health and General Preventive Medicine

Faculty Disclosures:
Absalon D Gutierrez, MD (Nothing to disclose - 09/08/2025)
Francesco Versace, PhD (Nothing to disclose - 09/16/2025)
Download Handout

1. Articulate research findings as they relate to cancer prevention; e.g., early screening detection, tobacco and smoking cessation, etc.
2. Recognize and reduce barriers to prevention comprehensively to increase the uptake of cancer prevention measures among patients, providers, and communities.
3. Advance collaboration and dialogue among clinicians, researchers, and study participants, cancer prevention and control efforts can become more holistic, patient-centered, and effective.
4. Execute and initiate new research projects, adaptations to ongoing research projects, or changes in practice to improve cancer prevention care with a systematic and strategic approach.

If you are interested in attending this series, contact Shari Taylor@[email protected] 

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
9/19/2025 12:00:00 PM	Pharmacogenetics of the Response to Semaglutide in Mexican-Americans with Prediabetes - Cancer Prevention and Control Grand Rounds -- 9/19/2025 9/19/2025 12:00:00 PM 9/19/2025 1:00:00 PM 11 MD Anderson - Main Building False MM/DD/YYYY	Pharmacogenetics of the Response to Semaglutide in Mexican-Americans with Prediabetes - Cancer Prevention and Control Grand Rounds -- 9/19/2025 This series will provide an overview of population and health services and research topics; i.e., collection, analysis and/or synthesis of health/practice data that improve health care or best practices. The goal is to address emerging areas relevant to cancer prevention research and practice, stimulate potential collaborations, and recognize and reduce barriers to prevention. Objective(s): 1 Articulate research findings as they relate to cancer prevention; e.g., early screening detection, tobacco and smoking cessation, etc. 2 Recognize and reduce barriers to prevention comprehensively to increase the uptake of cancer prevention measures among patients, providers, and communities. 3 Advance collaboration and dialogue among clinicians, researchers, and study participants, cancer prevention and control efforts can become more holistic, patient-centered, and effective. 4 Execute and initiate new research projects, adaptations to ongoing research projects, or changes in practice to improve cancer prevention care with a systematic and strategic approach. Location: MD Anderson - Main Building Specialties: Gastroenterology, Gynecologic Oncology, Infectious Disease, Internal Medicine, Pulmonary Disease, Radiation Oncology, Preventive Medicine, Psychiatry, Public Health and General Preventive Medicine Faculty Disclosures: Absalon D Gutierrez, MD (Nothing to disclose - 09/08/2025) Francesco Versace, PhD (Nothing to disclose - 09/16/2025) Download Handout Location: MD Anderson - Main Building Specialties: Gastroenterology, Gynecologic Oncology, Infectious Disease, Internal Medicine, Preventive Medicine, Psychiatry, Public Health and General Preventive Medicine, Pulmonary Disease, Radiation Oncology